Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

Our Strategy and Values

The commercial strategy of the Group has a number of key elements:

Our Strategy

1

To make our lead product Feraccru® / Accrufer® (Ferric Maltol) available to as many patients as possible in collaboration with commercial partners

2

Effectively use clinical and pharmaco-economic data to support commercial partners

3

Engage with a well-resourced and ambitious partner to enable commercial success in the US market for Accrufer®

4

Establish Feraccru® / Accrufer® (Ferric Maltol) as the first choice for patients who have failed salt-based oral iron treatment

5

To maintain a scalable supportive infrastructure that facilitates product development and commercial success

6

To evaluate opportunities to out-licence PT20 to an attractive commercial partner

Our Values

  • Patient centric: The patients our therapies treat are at the heart of why we do it
  • Ethical: Always professional with the highest of standards
  • Product focused: We have a great track record of identifying value and are always looking for more
  • Freedom to operate: It is “our” Company and we avoid hierarchy, we challenge to succeed
  • Relationships: Strong and human… everyone is valuable
  • Continuously develop: We only want people who are committed, effective and determined to succeed